Azole drugs have differential efficacy in varied models of immunosuppression in larval zebrafish hosts
This study demonstrates the utility of the larval zebrafish host model for testing the efficacy of antifungal drugs in varied host backgrounds and determining the effects of these drugs on fungi living and growing inside infected hosts.
Authors
- Charles P. Davis (ORCID: https://orcid.org/0000-0002-7293-2769)
- Savini Thrikawala (ORCID: https://orcid.org/0000-0002-4617-7552)
- Hannah Pollock
- Sarah E. Baum (ORCID: https://orcid.org/0000-0002-5805-1084)
- Emily E. Rosowski (ORCID: https://orcid.org/0000-0002-6761-1098)
- Molly Anderson (ORCID: https://orcid.org/0000-0002-4972-1648)
- Kevin E. Ayala (ORCID: https://orcid.org/0009-0002-0674-3967)
- M. Lynette Goins
Institutions
- University of South Carolina (US)
- Clemson University (US)
Publication Details
- Journal
- Future Microbiology
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/17460913.2025.2539639
- Primary Topic
- Zebrafish Biomedical Research Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases